Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system

Journal of Nutritional Biochemistry

Volumn 25, Issue 8, 2014, Pages 875-884

  Wilfinger, Julia ^a   Seuter, Sabine ^a   Tuomainen, Tomi Pekka ^a   Virtanen, Jyrki K ^a   Voutilainen, Sari ^a   Nurmi, Tarja ^a   de Mello, Vanessa D F ^a   Uusitupa, Matti ^a   Carlberg, Carsten ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Biomarker; Chromatin; Gene regulation; Primary vitamin D target genes; Vitamin D receptor

Indexed keywords

CALCITRIOL; CARRIER PROTEIN; CD97 ANTIGEN; GLUCOSE TRANSPORTER; LEUCINE RICH REPEAT CONTAINING 8A; RECEPTOR INTERACTING PROTEIN 140; SODIUM PHOSPHATE COTRANSPORTER 37A2; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; ANTIPORTER; BIOLOGICAL MARKER; CALCITRIOL RECEPTOR; CHROMATIN; COLECALCIFEROL; FAS ANTIGEN; LRRC8A PROTEIN, HUMAN; MEMBRANE PROTEIN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SLC37A2 PROTEIN, HUMAN; VDR PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CHROMATIN; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; AGED; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ANTIGENS, CD95; ANTIPORTERS; BINDING SITES; BIOLOGICAL MARKERS; CALCITRIOL; CHOLECALCIFEROL; CHROMATIN; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; NUCLEAR PROTEINS; PREDIABETIC STATE; RECEPTORS, CALCITRIOL;

EID: 84903764365     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.04.002     Document Type: Article

References (58)

1. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689S-1696S.
2. Ingraham B.A., Bragdon B., Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008, 24:139-149.
3. Verstuyf A., Carmeliet G., Bouillon R., Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int 2010, 78:140-145.
4. 3 in skin. Biochem Biophys Res Commun 1977, 76:107-114.
5. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005, 135:317-322.
6. Carlberg C., Molnár F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 2012, 12:528-547.
7. Perissi V., Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 2005, 6:542-554.
8. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010, 20:1352-1360.
9. 3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 2011, 39:9181-9193.
10. Kovalenko P.L., Zhang Z., Cui M., Clinton S.K., Fleet J.C. 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. BMC Genomics 2010, 11:26.
11. 3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One 2013, 8:e58725.
12. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011, 7:337-345.
13. 3-dependent repression of interleukin-12B. Biochim Biophys Acta 1813, 2011:810-818.
14. 3 on IL-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta 1803, 2010:1276-1286.
15. FANTOM-Consortium, Suzuki H., Forrest A.R., van Nimwegen E., Daub C.O., Balwierz P.J., et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet 2009, 41:553-562.
16. Gibcus J.H., Dekker J. The hierarchy of the 3D genome. Mol Cell 2013, 49:773-782.
17. Schmidt D., Schwalie P.C., Wilson M.D., Ballester B., Gonçalves A., Kutter C., et al. Waves of retrotransposon expansion remodel genome organization and CTCF binding in multiple mammalian lineages. Cell 2012, 148:335-348.
18. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
19. ENCODE-Project-Consortium, Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
20. Seuter S., Neme A., Carlberg C. Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening. PLoS ONE 2014, 9:e96184.
21. 3 and its receptor. J Steroid Biochem Mol Biol 2007, 103:389-395.
22. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 2008, 66:S98-S112.
23. Carlberg C., Campbell M.J. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 2013, 78:127-136.
24. Carlberg C., Seuter S. Dynamics of nuclear receptor target gene regulation. Chromosoma 2010, 119:479-484.
25. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J 1998, 17:4905-4908.
26. Eberharter A., Becker P.B. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 2002, 3:224-229.
27. Giresi P.G., Kim J., McDaniell R.M., Iyer V.R., Lieb J.D. FAIRE (formaldehyde-assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin. Genome Res 2007, 17:877-885.
28. Giresi P.G., Lieb J.D. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (formaldehyde assisted isolation of regulatory elements). Methods 2009, 48:233-239.
29. Song L., Zhang Z., Grasfeder L.L., Boyle A.P., Giresi P.G., Lee B.K., et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res 2011, 21:1757-1767.
30. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
31. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:R34.
32. 3 supplementation. PLoS One 2013, 8:e71042.
33. 2 analyses. Anal Biochem 2013, 435:1-9.
34. Tuomainen T.P., Virtanen J.K., Voutilainen S., Nurmi T., Mursu J., Laaksonen V., et al. Glucose metabolism effects of vitamin D supplementation in prediabetes - the VitDmet study 2014, [submitted].
35. de Mello V.D., Erkkila A.T., Schwab U.S., Pulkkinen L., Kolehmainen M., Atalay M., et al. The effect of fatty or lean fish intake on inflammatory gene expression in peripheral blood mononuclear cells of patients with coronary heart disease. Eur J Nutr 2009, 48:447-455.
36. Thorvaldsdottir H., Robinson J.T., Mesirov J.P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013, 14:178-192.
37. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res 2002, 12:996-1006.
38. Klein E., Ben-Bassat H., Neumann H., Ralph P., Zeuthen J., Polliack A., et al. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 1976, 18:421-431.
39. 3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Res 2013, 41:110-124.
40. Seuter S., Pehkonen P., Heikkinen S., Carlberg C. Dynamics of 1α,25-dihydroxyvitamin D-dependent chromatin accessibility of early vitamin D receptor target genes. Biochim Biophys Acta 2013, 1829:1266-1275.
41. Standahl Olsen K., Rylander C., Brustad M., Aksnes L., Lund E. Plasma 25 hydroxyvitamin D level and blood gene expression profiles: a cross-sectional study of the Norwegian Women and Cancer Post-genome Cohort. Eur J Clin Nutr 2013, 67:773-778.
42. Hamann J., Veninga H., de Groot D.M., Visser L., Hofstra C.L., Tak P.P., et al. CD97 in leukocyte trafficking. Adv Exp Med Biol 2010, 706:128-137.
43. Abascal F., Zardoya R. LRRC8 proteins share a common ancestor with pannexins, and may form hexameric channels involved in cell-cell communication. Bioessays 2012, 34:551-560.
44. Pan C.J., Chen S.Y., Jun H.S., Lin S.R., Mansfield B.C., Chou J.Y. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One 2011, 6:e23157.
45. Nautiyal J., Christian M., Parker M.G. Distinct functions for RIP140 in development, inflammation, and metabolism. Trends Endocrinol Metab 2013, 24:451-459.
46. 3 receptors. Cell 1991, 65:1255-1266.
47. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L.J., Grippo J.F., et al. Two nuclear signalling pathways for vitamin D. Nature 1993, 361:657-660.
48. Meyer M.B., Goetsch P.D., Pike J.W. VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol Endocrinol 2012, 26:37-51.
49. Ding N., Yu R.T., Subramaniam N., Sherman M.H., Wilson C., Rao R., et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013, 153:601-613.
50. Misteli T. Beyond the sequence: cellular organization of genome function. Cell 2007, 128:787-800.
51. Engelman C.D., Meyers K.J., Iyengar S.K., Liu Z., Karki C.K., Igo R.P., et al. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr 2013, 143:17-26.
52. Engelman C.D., Fingerlin T.E., Langefeld C.D., Hicks P.J., Rich S.S., Wagenknecht L.E., et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 2008, 93:3381-3388.
53. Orton S.M., Morris A.P., Herrera B.M., Ramagopalan S.V., Lincoln M.R., Chao M.J., et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008, 88:441-447.
54. Snellman G., Melhus H., Gedeborg R., Olofsson S., Wolk A., Pedersen N.L., et al. Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One 2009, 4:e7747.
55. Steel J.H., White R., Parker M.G. Role of the RIP140 corepressor in ovulation and adipose biology. J Endocrinol 2005, 185:1-9.
56. Institute-of-Medicine. Dietary reference intakes for calcium and vitamin D 2011, National Academies Press, Washington, DC.
57. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
58. Dastani Z., Li R., Richards B. Genetic regulation of vitamin d levels. Calcif Tissue Int 2013, 92:106-117.